| Ginkgo Bioworks Inc.. (9/27/23). "Press Release: Ginkgo Bioworks Announces Multi-Target RNA Discovery Collaboration with Pfizer". Boston, MA. |
2023-09-27 |
| Twist Bioscience Corporation. (9/27/23). "Press Release: Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases". South San Francisco, CA & Rafael, CA & Barcelona. |
2023-09-27 |
| Novo Nordisk A/S. (9/25/23). "Press Release: Valo Health and Novo Nordisk to Collaborate to Discover and Develop Novel Treatments for Cardiometabolic Diseases Using Human Data and Artificial Intelligence". Bagsværd & Boston, MA. |
2023-09-25 |
| Rentschler Biopharma SE. (9/19/23). "Press Release: Rentschler Biopharma Appoints Benedikt von Braunmuehl as Chief Executive Officer". Laupheim, Stevenage & Milford, MA. |
2023-09-19 |
| Scinai Immunotherapeutics Ltd.. (9/19/23). "Press Release: Scinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct Offering". Jerusalem. |
2023-09-19 |
| BenevolentAI. (9/18/23). "Press Release: BenevolentAI Welcomes Christina Busmalis as its New Chief Revenue Officer". London. |
2023-09-18 |
| Bruker Corporation. (9/18/23). "Press Release: Bruker Introduces Novel 4D-Proteomics timsTOF Capabilities". Busan. |
2023-09-18 |
| Broken String Biosciences Ltd.. (9/18/23). "Press Release: Broken String Biosciences Closes $15M Series A Funding Round". Cambridge. |
2023-09-18 |
| Scinai Immunotherapeutics Ltd.. (9/15/23). "Press Release: Scinai Immunotherapeutics Announces $1.33 Million Registered Direct Offering". Jerusalem. |
2023-09-15 |
| ICR Inc.. (9/12/23). "Press Release: ICR Acquires Consilium Strategic Communications, Creating Global Leader in Healthcare Communications and Investor Relations". New York, NY. |
2023-09-12 |
| Qiagen N.V.. (9/11/23). "Press Release: Qiagen Launches API to Streamline Access to World-leading Biomedical Data for AI Integration". Venlo & Redwood City, CA. |
2023-09-11 |
| Immatics N.V.. (9/11/23). "Press Release: Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics". Cambridge, MA & Tübingen. |
2023-09-11 |
| Scinai Immunotherapeutics Ltd.. (9/11/23). "Press Release: Scinai Immunotherapeutics Ltd. to Participate This Week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston". Jerusalem. |
2023-09-11 |
| Verge Analytics, Inc. (d/b/a Verge Genomics). (9/8/23). "Press Release: Verge Genomics Announces Artificial Intelligence-enabled Drug Discovery Collaboration with Alexion for Rare Neurodegenerative and Neuromuscular Diseases". South San Francisco, CA. |
2023-09-08 |
| Mariana Oncology Inc.. (9/7/23). "Press Release: Mariana Oncology Announces $175 Million Series B Financing". Watertown, MA. |
2023-09-07 |
| Corteria Pharmaceuticals S.A.S.. (9/7/23). "Press Release: Corteria Pharmaceuticals Announces a €65M ($71M) Financing to Advance Transformational Medicines in Cardiovascular Diseases". Paris. |
2023-09-07 |
| Agilent Technologies Inc.. (9/5/23). "Press Release: Agilent Names Philip Binns to Lead Life Sciences and Applied Markets Group". Santa Clara, CA. |
2023-09-05 |
| Illumina, Inc.. (9/5/23). "Press Release: Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer". San Diego, CA. |
2023-09-05 |
| Exscientia plc. (8/31/23). "Press Release: Exscientia to Present at Upcoming Investor Conferences in September". Oxford. |
2023-08-31 |
| Optibrium Ltd.. (8/31/23). "Press Release: Optibrium Acquires BioPharmics LLC, Expanding Its 3D Drug Design and Visualisation Offering". Cambridge. |
2023-08-31 |
| Bayer AG. (8/30/23). "Press Release: Strong Commitment to Modern Crop Protection Made in Europe.
Bayer to Invest EUR 220 Million in New R&D Facility at Its Monheim Site". Monheim. |
2023-08-30 |
| Golgi Neurosciences S.r.l.. (8/29/23). "Press Release: Golgi Neurosciences Partners with CDD Vault to Drive Innovation in Neurodegenerative Disease Treatment". Milano & San Francisco, CA. |
2023-08-29 |
| Bayer AG. (8/29/23). "Press Release: Gene Editing – Pairwise and Bayer Start New Five-year Multi-million Dollar Collaboration to Further Advance Short-stature Corn". Durham, NC & Monheim. |
2023-08-29 |
| NanoString Technologies, Inc.. (8/28/23). "Press Release: NanoString Appoints Todd Garland as Chief Commercial Officer". Seattle, WA. |
2023-08-28 |
| Danaher Corporation. (8/28/23). "Press Release: Danaher to Acquire Abcam". Washington, DC. |
2023-08-28 |
| Illumina, Inc.. (8/28/23). "Press Release: Illumina to Webcast Upcoming Investor Conference". San Diego, CA. |
2023-08-28 |
| Synthego Corporation. (8/24/23). "Press Release: Synthego and bit.bio Expand Strategic Partnership to Build a Platform for the Development of Safer and More Efficient Genetic Engineering of Human Cells for Cell Therapies". Redwood City, CA & Cambridge. |
2023-08-24 |
| AiCuris Anti-infective Cures AG. (8/23/23). "Press Release: AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of Prevymis (letermovir) in Second Indication". Wuppertal. |
2023-08-23 |
| Agenus Inc.. (8/23/23). "Press Release: Agenus Prioritizes Resources to Accelerate Registration and Commercialization of BOT/BAL Program in Multiple Cancers". Lexington, MA. |
2023-08-23 |
| BlueRock Therapeutics LP. (8/23/23). "Press Release: BlueRock’s Phase I Study with Bemdaneprocel in Patients with Parkinson’s Disease Meets Primary Endpoint". Wuppertal. |
2023-08-23 |
| Rapport Therapeutics, Inc.. (8/23/23). "Press Release: Rapport Therapeutics Raises $150 Million in Series B Funding Round and Announces Key Board Appointments to Further Advance Precision Neuromedicine Platform". Boston, MA & San Diego, CA. |
2023-08-23 |
| AlphaSense Inc.. (8/23/23). "Press Release: AlphaSense Continues Global Expansion in Asia Pacific with New Regional Hub in Singapore". New York, NY. |
2023-08-23 |
| Abivax S.A.. (8/23/23). "Press Release: Abivax Appoints Patrick Malloy as Senior Vice President Investor Relations". Paris. |
2023-08-23 |
| Sartorius AG. (8/17/23). "Press Release: Sartorius and Repligen Corporation Launch Integrated System with Biostat STR and XCell ATF for Upstream Process Intensification". Göttingen. |
2023-08-17 |
| Bruker Corporation. (8/17/23). "Press Release: Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction". Billerica, MA & Emeryville, CA. |
2023-08-17 |
| Pieris Pharmaceuticals, Inc.. (8/17/23). "Press Release: Pieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals' Initiation of Phase 1/2 Study of BOS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific". Boston, MA. |
2023-08-17 |
| Novo Nordisk A/S. (8/10/23). "Press Release: Novo Nordisk to Acquire Inversago Pharma to Develop New Therapies for People Living with Obesity, Diabetes and other Serious Metabolic Diseases". Bagsværd & Montreal. |
2023-08-10 |
| Alltrna. (8/9/23). "Press Release: Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease". Cambridge, MA. |
2023-08-09 |
| IO Biotech, Inc.. (8/7/23). "Press Release: IO Biotech, Inc. Announces $75 Million Private Placement Financing". New York, NY. |
2023-08-07 |
| Gracell Biotechnologies Inc.. (8/7/23). "Press Release: Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors". San Diego, CA, Suzhou & Shanghai. |
2023-08-07 |
| Lena Biosciences, Inc.. (8/7/23). "Press Release: Lena Biosciences Appoints Dr. Eckhard von Keutz to Its Business Advisory Board and Science Advisory Board". |
2023-08-07 |
| 3D Systems, Inc.. (8/7/23). "Press Release: 3D Systems & Theradaptive Establish Commercial Partnership to Advance Orthopedic & Soft Tissue Repair Using Breakthrough Regenerative Therapeutics". Rock Hill, SC & Frederick, MD. |
2023-08-07 |
| NeuBase Therapeutics, Inc.. (8/3/23). "Press Release: NeuBase Therapeutics to Explore Strategic Alternatives". Pittsburgh, PA. |
2023-08-03 |
| BiondVax Pharmaceuticals Ltd.. (8/1/23). "Press Release: Nasdaq Grants BiondVax Extension to Regain Compliance with Listing Rules". Jerusalem. |
2023-08-01 |
| Sygnature Discovery Ltd.. (7/31/23). "Press Release: Sygnature Discovery Accelerates Global Growth with Major North American Acquisition". |
2023-07-31 |
| Biogen Inc.. (7/28/23). "Press Release: Biogen to Acquire Reata Pharmaceuticals". Cambridge, MA & Plano, TX. |
2023-07-28 |
| Revvity, Inc.. (7/27/23). "Press Release: Revvity Signals Software and Scitara Expand Strategic Relationship to Accelerate Laboratory Digital Transformation". Waltham, MA. |
2023-07-27 |
| Kriya Therapeutics, Inc.. (7/26/23). "Press Release: Kriya Announces $150 Million Addition to Its Series C, Bringing Total Round to over $430 Million to Further Its Mission of Delivering Gene Therapies for Prevalent Diseases". Palo Alto, CA & Research Tr |
2023-07-26 |
| Qiagen N.V.. (7/26/23). "Press Release: Bio-Rad and Qiagen Announce Patent Settlement and Cross-licensing Agreement". Venlo. |
2023-07-26 |
| Immatics N.V.. (7/24/23). "Press Release: Immatics Announces $35 Million Equity Investment from Bristol Myers Squibb". Tübingen & Houston, TX. |
2023-07-24 |
| Roche. (7/24/23). "Press Release: Roche Enters Partnership with Alnylam to Co-develop and Co-commercialise RNAi Therapeutic Zilebesiran to Treat Hypertension in Patients with High Cardiovascular Risk". Basel. |
2023-07-24 |
| Epigenomics AG. (7/24/23). "Press Release: Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets". Berlin. |
2023-07-24 |
| ADC Therapeutics S.A.. (7/20/23). "Press Release: ADC Therapeutics Announces Plan to Discontinue the Phase 2 LOTIS-9 Clinical Trial of Zynlonta (loncastuximab tesirine-lpyl) and Rituximab in Unfit or Frail Previously Untreated DLBCL Patients". Lausanne. |
2023-07-20 |
| Organomation. (7/20/23). "Press Release: Organomation Partners with Orange Science to Distribute Sample Concentrators in Japan". |
2023-07-20 |
| Tillotts Pharma AG. (7/20/23). "Press Release: Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis". Montréal, Munich & Rheinfelden. |
2023-07-20 |
| Argenx SE. (7/18/23). "Press Release: Argenx Raises $1.1 Billion in Gross Proceeds in a Global Offering". Amsterdam. |
2023-07-18 |
| Illumina, Inc.. (7/18/23). "Press Release: The Alliance for Genomic Discovery Announces Founding Biopharma Members – AbbVie, Amgen, AstraZeneca, Bayer, and Merck". San Diego, CA. |
2023-07-18 |
| Bicycle Therapeutics plc. (7/18/23). "Press Release: Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Cambridg |
2023-07-18 |
| Pieris Pharmaceuticals, Inc.. (7/18/23). "Press Release: Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring". Boston, MA. |
2023-07-18 |
| Novartis AG. (7/17/23). "Press Release: Novartis Builds on Neuroscience Pipeline and xRNA Platform Capabilities with Acquisition of DTx Pharma". Basel. |
2023-07-17 |
| Atavistik Bio Inc.. (7/17/23). "Press Release: Atavistik Bio Appoints Bryan Stuart as Chief Executive Officer". Cambridge, MA. |
2023-07-17 |
| Argenx SE. (7/17/23). "Press Release: Argenx Announces Launch of Proposed Global Offering". Amsterdam. |
2023-07-17 |
| Galmed Pharmaceuticals Ltd.. (7/14/23). "Press Release: Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering". Tel Aviv. |
2023-07-14 |
| Revvity, Inc.. (7/13/23). "Press Release: Revvity Establishes Scientific Centre of Excellence for Genomic Insight in Cambridge". Cambridge. |
2023-07-13 |
| Bicycle Therapeutics plc. (7/12/23). "Press Release: Bicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares". Cambridge & Boston, MA. |
2023-07-12 |
| Merck KGaA. (7/12/23). "Press Release: Merck Invests € 23 Million to Expand Cell Culture Media Production in Kansas, USA". Darmstadt. |
2023-07-12 |
| Bicycle Therapeutics plc. (7/12/23). "Press Release: Bicycle Therapeutics Announces Proposed $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares". Cambridge & Boston, MA. |
2023-07-12 |
| Evotec SE. (7/11/23). "Press Release: Evotec and Bristol Myers Squibb Enter Licence Agreement within Neuroscience Partnership". Hamburg. |
2023-07-11 |
| Abivax S.A.. (7/11/23). "Press Release: Abivax Announces the Appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors". Paris. |
2023-07-11 |
| Ramarketing & PR Ltd.. (7/11/23). "Press Release: Ramarketing Announces North American Expansion". |
2023-07-11 |
| Crossbow Therapeutics, Inc-. (7/11/23). "Press Release: Crossbow Therapeutics Launches with $80 Million in Series A Financing to Advance a Novel Class of Antibody Therapies that Mimic T-Cell Receptors to Treat Cancer". Cambridge, MA. |
2023-07-11 |
| Gamma Biosciences. (6/30/23). "Press Release: Univercells Technologies Acquired by Donaldson Company". Menlo Park, CA. |
2023-06-30 |
| Donaldson Company, Inc.. (6/29/23). "Press Release: Donaldson Acquires Univercells Technologies, Broadens Life Sciences Reach". Minneapolis, MN. |
2023-06-29 |
| BioNTech SE. (6/29/23). "Press Release: BioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLC". Mainz & Rockville, MD. |
2023-06-29 |
| Eli Lilly and Company. (6/29/23). "Press Release: Lilly to Acquire Sigilon Therapeutics". Indianapolis, IN & Cambridge, MA. |
2023-06-29 |
| Synthego Corporation. (6/28/23). "Press Release: Synthego and ATCC Enter Alliance for Cutting-Edge Gene Editing of Mammalian and Mouse Cell Lines". Redwood City, CA. |
2023-06-28 |
| MoonLake Immunotherapeutics AG. (6/28/23). "Press Release: MoonLake Immunotherapeutics Announces Pricing of $400 Million Upsized Public Offering of Class A Ordinary Shares". Zug. |
2023-06-28 |
| Helmholtz-Zentrum für Infektionsforschung (HZI. (6/27/23). "Press Release: Geneticist Josef Penninger Becomes New Scientific Director of the Helmholtz Centre for Infection Research". |
2023-06-27 |
| AC Immune S.A.. (6/27/23). "Press Release: AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease". Lausanne. |
2023-06-27 |
| MoonLake Immunotherapeutics AG. (6/26/23). "Press Release: MoonLake Immunotherapeutics Announces Proposed Underwritten Public Offering". Zug. |
2023-06-26 |
| MoonLake Immunotherapeutics AG. (6/25/23). "Press Release: MoonLake Immunotherapeutics Achieves Landmark Milestone with Positive Phase 2 Results for Nanobody Sonelokimab in Hidradenitis Suppurativa". Zug. |
2023-06-25 |
| Bicycle Therapeutics plc. (6/23/23). "Press Release: Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer". Cambridge & Boston, MA. |
2023-06-23 |
| Abcam plc. (6/23/23). "Press Release: Abcam Announces Review of Strategic Alternatives". Cambridge & Waltham, MA. |
2023-06-23 |
| SareptaTherapeutics, Inc.. (6/22/23). "Press Release: Sarepta Therapeutics Announces FDA Approval of ELEVIDYS, the First Gene Therapy to Treat Duchenne Muscular Dystrophy". Cambridge, MA. |
2023-06-22 |
| Memo Therapeutics AG. (6/22/23). "Press Release: Memo Therapeutics AG Starts U.S. Pivotal Phase II/III Clinical Trial with AntiBKV for Treatment of BKV Infection in Renal Transplant Patients". Schlieren. |
2023-06-22 |
| Lunaphore Technologies S.A.. (6/22/23). "Press Release: Lunaphore to Get Acquired by Bio-Techne". Tolochenaz & Minneapolis, MN. |
2023-06-22 |
| SandboxAQ. (6/22/23). "Press Release: SandboxAQ Announces Biopharma Molecular Simulation Division to Speed Life-Saving Drugs to Patients Through AI and Quantum Solutions". Palo Alto, CA. |
2023-06-22 |
| Pieris Pharmaceuticals, Inc.. (6/21/23). "Press Release: Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase 2a Trial of Elarekibep (PRS-060/AZD1402) Due to New Non-Clinical Safety Findings From 13-week Toxicology Study". Boston, MA. |
2023-06-21 |
| MaaT Pharma. (6/21/23). "Press Release: MaaT Pharma Announces New Appointments to the Board and Executive Team". Lyon. |
2023-06-21 |
| Eli Lilly and Company. (8/20/23). "Press Release: Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology". San Francisco, CA. |
2023-06-20 |
| Delve Bio. (8/20/23). "Press Release: Delve Bio Launches to Commercialize its Metagenomic Sequencing Platform for Infectious Disease Diagnosis". San Francisco, CA. |
2023-06-20 |
| Upstream Bio (US). (6/20/23). "Press Release: Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases". Allschwil. |
2023-06-20 |
| Mainz Biomed N.V.. (6/15/23). "Press Release: Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference". Mechelen. |
2023-06-15 |
| Theradaptive, Inc.. (6/15/23). "Press Release: Theradaptive Closes $26 Million Series A Investment Round". Frederick, MD. |
2023-06-15 |
| Galapagos N.V.. (6/15/23). "Press Release: Galapagos Appoints Thad Huston as Chief Financial Officer and Chief Operating Officer". Mechelen. |
2023-06-15 |
| Centogene N.V.. (6/14/23). "Press Release: Centogene Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency". Cambirdge, MA, Rostock & Berlin. |
2023-06-14 |
| Qiagen N.V.. (6/13/23). "Press Release: Danish National Genome Center Selects Qiagen for Variant Interpretation in Oncology Genome Sequencing". Venlo & Redwood City, CA. |
2023-06-13 |
| CRISPR Therapeutics AG. (6/13/23). "Pressemitteilung: CRISPR Therapeutics to Participate in Goldman Sachs 44th Annual Global Healthcare Conference". Zug & Cambridge, MA. |
2023-06-13 |
| Novartis AG. (6/12/23). "Pressemitteilung: Novartis Bolsters Innovative Medicines Strategy and Renal Pipeline with Agreement to Acquire Chinook Therapeutics for USD 3.2bn Upfront (USD 40 / Share)". Basel. |
2023-06-12 |
| Agilent Technologies Inc.. (6/12/23). "Press Release: Agilent Introduces New Comprehensive GPC/SEC Solutions at HPLC 2023 Conference". Santa Clara, CA. |
2023-06-12 |
![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
